May 7, 2021 VIEW NOW: COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop The Patient-Reported Outcome Consortium’s Rare Disease Subcommittee is pleased to invite you to view the complimentary virtual w
May 7, 2021 COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop Friday May 7, 2021 12:00 – 1:30 pm Ea
May 7, 2021 Pediatric COVID-19 Mitigation Strategies Virtual Workshop Click here for WebEx link On May 7th, 2021, 12:00-1:30 PM Eastern Time (US), the PRO Consortium and Rare Disease Su
May 7, 2021 COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop The Patient-Reported Outcome Consortium’s Rare Disease Subcommittee is pleased to invite you to view the complimentary virtual w
April 21, 2021 View Now | RDCA-DAP: Searching, visualizing and exploring data in the RDCA-DAP platform to identify data of interest for advanced analysis When: April 21, 2021, 12 p.m. ET Example Disease: Friedreich’s ataxia Presenters: Amanda Borens, MSc, Executiv
April 15, 2021-April 16, 2021 View Now: 12th Annual Patient-Reported Outcome Consortium Workshop – Held Virtually April 14–15, 2021 On April 14–15, 2021, the 12th Annual Patient-Reported Outcome Consortium Workshop was held in a virtual f
April 14, 2021-April 15, 2021 Identifying COAs for Use in Rare Disease Treatment Trials Presented at the PRO Consortium 2021 Workshop, held virtually April 14-15, 2021:
April 14, 2021-April 15, 2021 View Now: 12th Annual Patient-Reported Outcome Consortium Workshop – Held Virtually April 14–15, 2021 On April 14–15, 2021, the 12th Annual Patient-Reported Outcome Consortium Workshop was held in a virtual f
April 7, 2021 Development of a regulatory-ready clinical trial simulation tool for Duchenne muscular dystrophy poster WMS 2020
April 7, 2021 Development of a regulatory-ready clinical trial simulation tool for Duchenne muscular dystrophy Abstract WMS 2020
